Literature DB >> 19471109

Neural ganglioside GD2 identifies a subpopulation of mesenchymal stem cells in umbilical cord.

Jie Xu1, WenBin Liao, DongSheng Gu, Lu Liang, Meng Liu, WeiTing Du, PengXia Liu, Lei Zhang, ShiHong Lu, ChunLan Dong, Bin Zhou, Zhongchao Han.   

Abstract

In contrast to hematopoietic stem cells, there is still a lack of definitive cell markers for specific isolation and identification of mesenchymal stem cells (MSCs). Thus a homogenous population of MSCs is only obtained after several passages, when multilineage potential or other distinctive features of very early progenitors may be already somewhat compromised. Recently a novel surface marker the neural ganglioside GD2 has been reported to distinguish MSCs from all other cells within marrow. Here, we found that MSCs derived from umbilical cord (UC-MSCs) also expressed this marker at early-passages. More importantly, UC-MSCs were the only cells within umbilical cord expressing this marker. Compared to unsorted cells, GD2(+)-sorted cells not only possessed much higher clonogenicity and proliferation capacity but also had significantly stronger multi-differentiation potentials. Flow cytometric analysis revealed that GD2(+)-sorted cells showed increased expression of SSEA-4, Oct-4, Sox-2 and Nanog, the typical markers expressed in embryonic stem cells, in comparison to unsorted or GD2-negative MSCs. Take together, our data demonstrate that the cells selected by GD2 are a subpopulation of MSCs with feature of primitive precursor cells and provide evidence that GD2 can be a cell surface marker suitable for the isolation and purification of UC-MSCs in early-passage culture. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19471109     DOI: 10.1159/000218188

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  25 in total

1.  GD2 expression is closely associated with neuronal differentiation of human umbilical cord blood-derived mesenchymal stem cells.

Authors:  Hye Jin Jin; Hae Yun Nam; Yun Kyong Bae; Soo Yeon Kim; I Rang Im; Wonil Oh; Yoon Sun Yang; Soo Jin Choi; Seong Who Kim
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

Review 2.  Stem cell glycolipids.

Authors:  Makoto Yanagisawa
Journal:  Neurochem Res       Date:  2010-12-16       Impact factor: 3.996

3.  microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis.

Authors:  Larissa A Gregory; Rachel A Ricart; Shyam A Patel; Philip K Lim; Pranela Rameshwar
Journal:  Curr Cancer Ther Rev       Date:  2011-08

Review 4.  Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord.

Authors:  Cun-Gang Fan; Qing-jun Zhang; Jing-ru Zhou
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

Review 5.  Reviewing and updating the major molecular markers for stem cells.

Authors:  Raquel Calloni; Elvira Alicia Aparicio Cordero; João Antonio Pêgas Henriques; Diego Bonatto
Journal:  Stem Cells Dev       Date:  2013-01-22       Impact factor: 3.272

Review 6.  Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential.

Authors:  Miaohua Mo; Shan Wang; Ying Zhou; Hong Li; Yaojiong Wu
Journal:  Cell Mol Life Sci       Date:  2016-05-03       Impact factor: 9.261

7.  Human dental stem cell derived transgene-free iPSCs generate functional neurons via embryoid body-mediated and direct induction methods.

Authors:  Ikbale El Ayachi; Jun Zhang; Xiao-Ying Zou; Dong Li; Zongdong Yu; Wei Wei; Kristen M S O'Connell; George T-J Huang
Journal:  J Tissue Eng Regen Med       Date:  2018-01-17       Impact factor: 3.963

8.  EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells.

Authors:  Sareetha Kailayangiri; Bianca Altvater; Stefanie Lesch; Sebastian Balbach; Claudia Göttlich; Johanna Kühnemundt; Jan-Henrik Mikesch; Sonja Schelhaas; Silke Jamitzky; Jutta Meltzer; Nicole Farwick; Lea Greune; Maike Fluegge; Kornelius Kerl; Holger N Lode; Nikolai Siebert; Ingo Müller; Heike Walles; Wolfgang Hartmann; Claudia Rossig
Journal:  Mol Ther       Date:  2019-02-23       Impact factor: 11.454

Review 9.  Membrane glycolipids in stem cells.

Authors:  Robert K Yu; Yusuke Suzuki; Makoto Yanagisawa
Journal:  FEBS Lett       Date:  2009-08-27       Impact factor: 4.124

Review 10.  Stem cell therapy in discogenic back pain.

Authors:  Ahmed H Barakat; Vivian A Elwell; Khai S Lam
Journal:  J Spine Surg       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.